A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2015 Nov 11

PMID 26553663

Citations 6

Authors

Luis Sambo

Margaret Chan

Steve Davis

Anthony Lake

Seth Berkley

Cyrus Poonawalla

Christopher J Elias

Affiliations

Soon will be listed here.

Citing Articles

Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.

Soeters H, Diallo A, Bicaba B, Kadade G, Dembele A, Acyl M J Infect Dis. 2019; 220(220 Suppl 4):S165-S174.

PMID: 31671441 PMC: 6853282. DOI: 10.1093/infdis/jiz358.

Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017.

Nnadi C, Oladejo J, Yennan S, Ogunleye A, Agbai C, Bakare L MMWR Morb Mortal Wkly Rep. 2017; 66(49):1352-1356.

PMID: 29240724 PMC: 5730219. DOI: 10.15585/mmwr.mm6649a3.

Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Mustapha M, Harrison L Hum Vaccin Immunother. 2017; 14(5):1107-1115.

PMID: 29211624 PMC: 5989898. DOI: 10.1080/21645515.2017.1412020.

Impact of serogroup A meningococcal conjugate vaccine for Africa.

Stuart J Hum Vaccin Immunother. 2017; 14(5):1116-1117.

PMID: 29194010 PMC: 5989890. DOI: 10.1080/21645515.2017.1412022.

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.

Diallo A, Soeters H, Yameogo I, Sawadogo G, Ake F, Lingani C PLoS One. 2017; 12(11):e0187466.

PMID: 29095907 PMC: 5667755. DOI: 10.1371/journal.pone.0187466.

References

Novak R, Kambou J, Diomande F, Tarbangdo T, Ouedraogo-Traore R, Sangare L . Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis. 2012; 12(10):757-64. PMC: 4831863. DOI: 10.1016/S1473-3099(12)70168-8. View

LaForce F, Okwo-Bele J . Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine. Health Aff (Millwood). 2011; 30(6):1049-57. DOI: 10.1377/hlthaff.2011.0328. View

. Meningococcal A conjugate vaccine: updated guidance, February 2015. Wkly Epidemiol Rec. 2015; 90(8):57-62. View

Daugla D, Gami J, Gamougam K, Naibei N, Mbainadji L, Narbe M . Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]. Lancet. 2013; 383(9911):40-47. PMC: 3898950. DOI: 10.1016/S0140-6736(13)61612-8. View

Kristiansen P, Diomande F, Ky Ba A, Sanou I, Ouedraogo A, Ouedraogo R . Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2012; 56(3):354-63. DOI: 10.1093/cid/cis892. View